Clin2
NCT06749665Likely a fitNot yet recruiting

Sclerotherapy vs candida antigen for common warts

Common Wart

Part of Infections, Skin clinical trials.

This study tests two treatments for common warts: a sclerotherapy injection and a candida antigen injection. The goal is to see which one works better to remove warts.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
75 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have common warts that have been diagnosed by a doctor.
  • You have not had any wart treatment in the past month.
  • You do not have kidney or liver disease.
  • You do not have a bleeding disorder or a history of blood clots.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07448844Recruiting· Phase 4
Comparing vitamin D3 and acyclovir shots for skin warts

This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.

Rawalpindi, Punjab Province
NCT03977753Recruiting· Phase 4
Study medicine to treat common, plantar, or flat warts

This trial tests two versions of an at-home medicine to see how well they clear warts. Participants are randomly assigned to the study medicine or a placebo (inactive treatment) so researchers can compare results fairly.

Arlon
NCT07543926Not yet recruiting
New Injectable Treatment for Common Warts

This study tests a new injection-based treatment for common warts (the bumpy growths on skin caused by a virus). Researchers want to see if this approach works better than current options and is safe for patients.

Sohag
NCT05291845Recruiting· Phase 2
Vaccine study for treating multiple common skin warts

This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.

Zagazig, Al Sharqia
NCT07246590Recruiting· Phase 3
Cantharidin treatment for common warts in children and adults

This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.

Saint Augustine, Florida
NCT07637734Not yet recruiting· Phase 3
Testing cantharidin treatment for common warts

This study tests whether cantharidin—a liquid applied directly to common warts—can safely and effectively remove them. Common warts are bumpy growths caused by a virus that appear on hands, feet, and other body areas.

Overland Park, Kansas

Hear when a new Common Wart trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.